Literature DB >> 6252168

Cefotaxime in the treatment of septicaemia and endocarditis.

M Armengaud, P Massip, J Aubertin, J M Ragnaud, A Bertrand, G Lepeu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6252168     DOI： 10.1093/jac/6.suppl_a.263

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Clinical experience of cefotaxime in infections caused by gram-positive pathogens.

Authors:  D Bassetti; M Solbiati; G Fraizzoli
Journal:  Infection       Date:  1985       Impact factor: 3.553

Review 2.  Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.

Authors:  A Adu; C L Armour
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

Review 3.  Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.